Gary H. Lyman

Appointments and Affiliations

Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Cancer Prevention Program
Full Member, Appointed: 2014
Fred Hutchinson Cancer Research Center
Hutchinson Institute for Cancer Outcomes Research (HICOR)
Co-Director, Appointed: 2014
University of Washington
School of Medicine
Division of Medical Oncology
Professor of Medicine, Appointed: 2014
University of Washington
Schools of Public Health and Pharmacy
Affiliate Professor, Appointed: 2014
Professional Headshot of NAME

Mailing Address

Fred Hutchinson Cancer Research Center
Mailstop M3-B232
P.O. Box 19024
Seattle, Washington 98109-1024
United States

Contact

Phone: (206) 667-6670
Fax: (206) 667-5977
glyman@fhcrc.org
http://www.fhcrc.org/en/labs/hicor.html

Degrees

M.P.H., Harvard University, School of Public Health, 1982.
M.D., State University of New York at Buffalo, School of Medicine, 1972.
B.A., State University of New York at Buffalo, Psychology and Physics, 1968.

Research Interests

Comparatice Effectiveness Research of Novel Diagnostic and Therapeutic Strategies
Clinical Decision Making, Risk Modeling, and Precision Medicine
Health Technology Assessment and Research Synthesis
Health Disparities and Quality of Cancer Care Delivery
Health Economics, Pharmacoeconomics and Healthcare Policy
Cancer Treatment and Supportive Care in the Elderly

Professional Societies

Fellow, Royal College of Physicians (Edinburgh)
Fellow, American College of Physicians
Fellow, American College of Clinical Pharmacology
Fellow, American College of Preventive Medicine
Fellow, American Society of Clinical Oncology
Member, American Association for Cancer Research
Member, American Society of Hematology
Member, International Society on Thrombosis and Haemostasis
Member, Multinational Association of Supportive Care in Cancer
Member, International Society for Pharmacoeconomics and Outcomes Research
Member, Society for Clinical Trials
Member, Society for Medical Decision Making
Member, Geriatric Oncology Consortium
Member, International Society of Geriatric Oncology
Member, Genomic Applications in Practice and Prevention Network (GAPPNet)
Member, European Society of Medical Oncology

Honors and Awards

Statesman Award, American Society of Clinical Oncology, 2010
Thomas C. Chalmers Award (VII Cochrane Colloquium, Rome Italy), 1999
Center Directors Award for Outstanding Research (H. Lee Moffitt Cancer Center), 1995, 1997
Best Scientific Presentation - Prevention 94, Atlanta, GA, 1994
The Honor Society of Phi Kappa Phi (University of South Florida), 1985
Special Clinical Fellow Award (Roswell Park Memorial Institute), 1977
Bernhardt and Sophie B. Gottlieb Award (State University of New York), 1972
James A. Gibson Honor Society (State University of New York), 1970

Board Certification and Eligibility

Advanced Achievement, American Board of Internal Medicine, 08-14-87
Diplomate, Subspecialty of Hematology, ABIM, 10-01-78
Diplomate, Subspecialty of Medical Oncology, ABIM, 10-18-77
Diplomate, American Board of Internal Medicine, 06-18-75
Diplomate, National Board of Medical Examiners, 07-02-73

Editorial Positions

Editor-In-Chief: Cancer Investigation
Editorial Board: Journal of Clinical Oncology
Advisory Editor: Cancer Treatment Reviews
Guest Editor: American Journal of Managed Care
Peer Review Editor: Journal of Oncology Practice
Board of Expert Moderators: Evidence for Genomic Applications
Associate Editor: Critical Reviews of Oncology and Hematology, Clinical Breast Cancer, Current Cancer Therapy Reviews, Comparative Effectiveness Research, Oncology & Biotech News
 
 
 

Recent Publications

2014
2013
Crawford, J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ et al..  2013.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(10):1266-90. Abstract
Hirsch, BR, Lyman GH.  2013.  Will biosimilars gain momentum? Journal of the National Comprehensive Cancer Network : JNCCN. 11(10):1291-7. Abstract
Lyman, GH.  2013.  Counting the costs of cancer care.. The lancet oncology. 14(12):1142-3.
Weycker, D, Barron R, Kartashov A, Legg J, Lyman GH.  2013.  Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. Abstract